Bank Of New York Mellon Corp Infinity Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.16 - $0.74 $9,088 - $42,034	56,804 New	56,804 $9.09 Million
Q4 2022 Feb 14, 2023	BUY	$0.46 - $1.21 $26,129 - $68,732	56,804 New	56,804 $31,000
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $100,832 - $246,936	-205,780 Reduced 77.81%	58,699 $37,000
Q1 2022 May 11, 2022	SELL	$0.85 - $2.4 $790 - $2,232	-930 Reduced 0.35%	264,479 $301,000
Q4 2021 Feb 11, 2022	BUY	$1.86 - $3.36 $7,536 - $13,614	4,052 Added 1.55%	265,409 $597,000
Q3 2021 Nov 12, 2021	BUY	$1.52 - $3.82 $35,905 - $90,236	23,622 Added 9.94%	261,357 $893,000
Q2 2021 Aug 11, 2021	BUY	$2.66 - $3.47 $464,696 - $606,202	174,698 Added 277.14%	237,735 $710,000
Q1 2021 May 13, 2021	SELL	$1.98 - $5.36 $12,804 - $34,663	-6,467 Reduced 9.3%	63,037 $203,000
Q3 2020 Nov 12, 2020	SELL	$0.82 - $1.34 $0 - $1	-1 Reduced -0.0%	69,504 $81,000
Q1 2020 May 06, 2020	SELL	$0.69 - $1.52 $284 - $627	-413 Reduced 0.59%	69,505 $58,000
Q1 2019 May 14, 2019	SELL	$1.18 - $1.91 $2,758 - $4,465	-2,338 Reduced 3.24%	69,918 $131,000
Q4 2018 Feb 11, 2019	BUY	$1.01 - $2.78 $30,928 - $85,129	30,622 Added 73.55%	72,256 $85,000
Q2 2018 Aug 06, 2018	SELL	$1.72 - $2.26 $13,558 - $17,815	-7,883 Reduced 15.92%	41,634 $80,000
Q1 2018 May 15, 2018	BUY	$1.8 - $2.74 $14,189 - $21,599	7,883 Added 18.93%	49,517 $104,000
Q4 2017 Feb 09, 2018	BUY	$1.22 - $3.73 $50,793 - $155,294	41,634	41,634 $85,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.